Amount$60M
Post-money valuation$220M
SeriesSeries D
AnnouncedJun 6, 2021
Time since last round3363 mo
SectorOphthalmology, Age Related Macular Degeneration (AMD), Diagnostics
Sub-sectorArtificial Intelligence, Computer Vision, Machine Learning
Strong
A strong, well-structured round.
Round size vs peers
In line with the typical Series D round.
Syndicate size
Healthy syndicate of 4 investors.
Insider conviction
2 existing investors re-upped — insiders doubling down.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series D rounds (1,000)
Round size distribution38th pct
smaller Series D roundslarger
Post-money valuation2th pct
$65Mthis round: $220M$6B
